Chemed Corporation
CHE
$439.36
-$2.19-0.50%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.54B | 2.53B | 2.53B | 2.51B | 2.49B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.54B | 2.53B | 2.53B | 2.51B | 2.49B |
| Cost of Revenue | 1.72B | 1.71B | 1.70B | 1.67B | 1.62B |
| Gross Profit | 822.54M | 823.18M | 832.13M | 845.22M | 866.66M |
| SG&A Expenses | 423.22M | 414.49M | 415.94M | 412.14M | 414.07M |
| Depreciation & Amortization | 65.70M | 64.84M | 64.34M | 63.81M | 63.26M |
| Other Operating Expenses | -59.00K | 0.00 | -63.00K | -52.00K | -41.00K |
| Total Operating Expenses | 2.21B | 2.19B | 2.18B | 2.14B | 2.10B |
| Operating Income | 333.68M | 343.86M | 351.92M | 369.32M | 389.36M |
| Income Before Tax | 348.94M | 355.78M | 370.46M | 387.94M | 410.65M |
| Income Tax Expenses | 89.16M | 90.54M | 91.65M | 97.60M | 101.92M |
| Earnings from Continuing Operations | 259.78 | 265.24 | 278.81 | 290.35 | 308.74 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 259.78M | 265.24M | 278.81M | 290.35M | 308.74M |
| EBIT | 333.68M | 343.86M | 351.92M | 369.32M | 389.36M |
| EBITDA | 395.07M | 404.40M | 411.96M | 428.83M | 448.32M |
| EPS Basic | 18.39 | 18.45 | 19.05 | 19.63 | 20.73 |
| Normalized Basic EPS | 15.69 | 15.72 | 15.84 | 16.41 | 17.25 |
| EPS Diluted | 18.35 | 18.37 | 18.92 | 19.46 | 20.54 |
| Normalized Diluted EPS | 15.66 | 15.65 | 15.72 | 16.26 | 17.08 |
| Average Basic Shares Outstanding | 56.65M | 57.60M | 58.46M | 59.09M | 59.60M |
| Average Diluted Shares Outstanding | 56.81M | 57.89M | 58.87M | 59.63M | 60.18M |
| Dividend Per Share | 2.30 | 2.20 | 2.10 | 2.00 | 1.90 |
| Payout Ratio | 12.53% | 11.95% | 11.01% | 10.17% | 9.19% |